This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Reprints and Permissions Copyright Information Books from ASM Press MicrobeWorld Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Ho, G. P. H. Articles by D'Andrea, A. D. Search for Related Content PubMed PubMed Citation Articles by Ho, G. P. H. Articles by D'Andrea, A. D.

Phosphorylation of FANCD2 on Two Novel Sites Is Required for Mitomycin C Resistance

Gary P. H. Ho, Steven Margossian, Toshiyasu Taniguchi, and Alan D. D'Andrea^*

Department of Radiation Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts

Received 17 October 2005/ Returned for modification 7 November 2005/ Accepted 24 May 2006

The Fanconi anemia (FA) pathway is a DNA damage-activated signaling pathway which regulates cellular resistance to DNA cross-linking agents. Cloned FA genes and proteins cooperate in this pathway, and monoubiquitination of FANCD2 is a critical downstream event. The cell cycle checkpoint kinase ATR is required for the efficient monoubiquitination of FANCD2, while another checkpoint kinase, ATM, directly phosphorylates FANCD2 and controls the ionizing radiation (IR)-inducible intra-S-phase checkpoint. In the present study, we identify two novel DNA damage-inducible phosphorylation sites on FANCD2, threonine 691 and serine 717. ATR phosphorylates FANCD2 on these two sites, thereby promoting FANCD2 monoubiquitination and enhancing cellular resistance to DNA cross-linking agents. Phosphorylation of the sites is required for establishment of the intra-S-phase checkpoint response. IR-inducible phosphorylation of threonine 691 and serine 717 is also dependent on ATM and is more strongly impaired when both ATM and ATR are knocked down. Threonine 691 is phosphorylated during normal S-phase progression in an ATM-dependent manner. These findings further support the functional connection of ATM/ATR kinases and FANCD2 in the DNA damage response and support a role for the FA pathway in the coordination of the S phase of the cell cycle.

Present address: Fred Hutchinson Cancer Research Center, Divisions of Human Biology and Public Health Sciences, Seattle, Wash.

This article has been cited by other articles:

• Guervilly, J.-H., Mace-Aime, G., Rosselli, F. (2008). Loss of CHK1 function impedes DNA damage-induced FANCD2 monoubiquitination but normalizes the abnormal G2 arrest in Fanconi anemia. Hum Mol Genet 17: 679-689 [Abstract] [Full Text]  
• Jacquemont, C., Taniguchi, T. (2007). Proteasome Function Is Required for DNA Damage Response and Fanconi Anemia Pathway Activation. Cancer Res. 67: 7395-7405 [Abstract] [Full Text]  
• Sobeck, A., Stone, S., Hoatlin, M. E. (2007). DNA Structure-Induced Recruitment and Activation of the Fanconi Anemia Pathway Protein FANCD2. Mol. Cell. Biol. 27: 4283-4292 [Abstract] [Full Text]  
• Matsuoka, S., Ballif, B. A., Smogorzewska, A., McDonald, E. R. III, Hurov, K. E., Luo, J., Bakalarski, C. E., Zhao, Z., Solimini, N., Lerenthal, Y., Shiloh, Y., Gygi, S. P., Elledge, S. J. (2007). ATM and ATR Substrate Analysis Reveals Extensive Protein Networks Responsive to DNA Damage. Science 316: 1160-1166 [Abstract] [Full Text]  
• Wang, X., Kennedy, R. D., Ray, K., Stuckert, P., Ellenberger, T., D'Andrea, A. D. (2007). Chk1-Mediated Phosphorylation of FANCE Is Required for the Fanconi Anemia/BRCA Pathway. Mol. Cell. Biol. 27: 3098-3108 [Abstract] [Full Text]